Pro/Con debate of activated protein C in severe sepsis.
Joore
J C A
JC
van Leeuwen
H J
HJ
Meulenbelt
J
J
Tobé
T J M
TJ
Fijen
J W
JW
Figen
J W
JW
D003362:Cost-Benefit Analysis; D006801:Humans; D011486:Protein C / Q000191:economics / Q000627:therapeutic use*; D018805:Sepsis / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D012720:Severity of Illness Index
D011486:Protein C